Literature DB >> 34860279

[Dual antiplatelet therapy can be discontinued as early as 1 month after coronary stent implantation].

Khosro Hekmat1, Christiane J Bruns2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34860279     DOI： 10.1007/s00104-021-01546-y

Source DB:  PubMed          Journal:  Chirurg        ISSN： 0009-4722            Impact factor:   0.955


× No keyword cloud information.
  2 in total

1.  2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).

Authors:  Marco Valgimigli; Héctor Bueno; Robert A Byrne; Jean-Philippe Collet; Francesco Costa; Anders Jeppsson; Peter Jüni; Adnan Kastrati; Philippe Kolh; Laura Mauri; Gilles Montalescot; Franz-Josef Neumann; Mate Petricevic; Marco Roffi; Philippe Gabriel Steg; Stephan Windecker; Jose Luis Zamorano; Glenn N Levine
Journal:  Eur Heart J       Date:  2018-01-14       Impact factor: 29.983

2.  Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk.

Authors:  Marco Valgimigli; Enrico Frigoli; Dik Heg; Jan Tijssen; Peter Jüni; Pascal Vranckx; Yukio Ozaki; Marie-Claude Morice; Bernard Chevalier; Yoshinobu Onuma; Stephan Windecker; Pim A L Tonino; Marco Roffi; Maciej Lesiak; Felix Mahfoud; Jozef Bartunek; David Hildick-Smith; Antonio Colombo; Goran Stanković; Andrés Iñiguez; Carl Schultz; Ran Kornowski; Paul J L Ong; Mirvat Alasnag; Alfredo E Rodriguez; Aris Moschovitis; Peep Laanmets; Michael Donahue; Sergio Leonardi; Pieter C Smits
Journal:  N Engl J Med       Date:  2021-08-28       Impact factor: 91.245
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.